COVID-19 and diffusing capacity of the lungs for carbon monoxide: a clinical biomarker in postacute care settings.
作者信息
Fuschillo Salvatore, Ambrosino Pasquale, Motta Andrea, Maniscalco Mauro
机构信息
Department of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri IRCCS, 27100, Pavia, Italy.
Institute of Biomolecular Chemistry, National Research Council, 80078, Pozzuoli, Naples, Italy.
出版信息
Biomark Med. 2021 Jun;15(8):537-539. doi: 10.2217/bmm-2021-0134. Epub 2021 May 14.
Abstract
摘要
相似文献
1
COVID-19 and diffusing capacity of the lungs for carbon monoxide: a clinical biomarker in postacute care settings.
Biomark Med. 2021 Jun;15(8):537-539. doi: 10.2217/bmm-2021-0134. Epub 2021 May 14.
2
Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge.
Respir Med. 2021 Jun;182:106394. doi: 10.1016/j.rmed.2021.106394. Epub 2021 Apr 15.
3
Lung diffusing capacity for nitric oxide and carbon monoxide following mild-to-severe COVID-19.
Physiol Rep. 2021 Feb;9(4):e14748. doi: 10.14814/phy2.14748.
4
Pulmonary diffusing capacity for carbon monoxide and nitric oxide after COVID-19: A prospective cohort study (the SECURe study).
Exp Physiol. 2024 May;109(5):652-661. doi: 10.1113/EP091757. Epub 2024 Mar 26.
5
Caution in interpretation of abnormal carbon monoxide diffusion capacity in COVID-19 patients.
Eur Respir J. 2021 Jan 28;57(1). doi: 10.1183/13993003.03263-2020. Print 2021 Jan.
6
Prognostic and pathophysiological marker for patients with chronic thromboembolic pulmonary hypertension: Usefulness of diffusing capacity for carbon monoxide at diagnosis.
Respirology. 2017 Jan;22(1):179-186. doi: 10.1111/resp.12883. Epub 2016 Sep 11.
7
Time delay effects in the estimation of pulmonary diffusing capacity.
Biomed Sci Instrum. 1975;11:25-30.
8
Historical review: the carbon monoxide diffusing capacity (DLCO) and its membrane (DM) and red cell (Theta.Vc) components.
Respir Physiol Neurobiol. 2003 Nov 14;138(2-3):115-42. doi: 10.1016/j.resp.2003.08.004.
9
Pulmonary veno-occlusive disease associated with severe reduction of single-breath carbon monoxide diffusing capacity.
Respiration. 1988;53(4):262-6. doi: 10.1159/000195438.
10
[Single-breath and rebreathing methods for measurement of pulmonary diffusing function: a comparative study].
Zhonghua Jie He He Hu Xi Za Zhi. 2013 Jul;36(7):510-5.
引用本文的文献
1
Effects of sulphur thermal water inhalations in long-COVID syndrome: Spa-centred, double-blinded, randomised case-control pilot study.
Clin Med (Lond). 2024 Nov;24(6):100251. doi: 10.1016/j.clinme.2024.100251. Epub 2024 Oct 5.
2
Pulmonary surfactant and COVID-19: A new synthesis.
QRB Discov. 2022 Apr 22;3:e6. doi: 10.1017/qrd.2022.1. eCollection 2022.
3
Idiopathic Pulmonary Fibrosis and Post-COVID-19 Lung Fibrosis: Links and Risks.
Microorganisms. 2023 Mar 30;11(4):895. doi: 10.3390/microorganisms11040895.
4
Effects of Comprehensive Rehabilitation on Pulmonary Function in Patients Recovering from COVID-19.
Int J Environ Res Public Health. 2023 Feb 23;20(5):3985. doi: 10.3390/ijerph20053985.
5
Evolution and long‑term respiratory sequelae after severe COVID-19 pneumonia: nitric oxide diffusion measurement value.
Respir Res. 2023 Feb 13;24(1):48. doi: 10.1186/s12931-023-02344-2.
Zotero 插件